180 related articles for article (PubMed ID: 30971822)
1. p38γ is essential for cell cycle progression and liver tumorigenesis.
Tomás-Loba A; Manieri E; González-Terán B; Mora A; Leiva-Vega L; Santamans AM; Romero-Becerra R; Rodríguez E; Pintor-Chocano A; Feixas F; López JA; Caballero B; Trakala M; Blanco Ó; Torres JL; Hernández-Cosido L; Montalvo-Romeral V; Matesanz N; Roche-Molina M; Bernal JA; Mischo H; León M; Caballero A; Miranda-Saavedra D; Ruiz-Cabello J; Nevzorova YA; Cubero FJ; Bravo J; Vázquez J; Malumbres M; Marcos M; Osuna S; Sabio G
Nature; 2019 Apr; 568(7753):557-560. PubMed ID: 30971822
[TBL] [Abstract][Full Text] [Related]
2. p38γ MAPK Is a Therapeutic Target for Triple-Negative Breast Cancer by Stimulation of Cancer Stem-Like Cell Expansion.
Qi X; Yin N; Ma S; Lepp A; Tang J; Jing W; Johnson B; Dwinell MB; Chitambar CR; Chen G
Stem Cells; 2015 Sep; 33(9):2738-47. PubMed ID: 26077647
[TBL] [Abstract][Full Text] [Related]
3. p38γ MAPK is required for inflammation-associated colon tumorigenesis.
Yin N; Qi X; Tsai S; Lu Y; Basir Z; Oshima K; Thomas JP; Myers CR; Stoner G; Chen G
Oncogene; 2016 Feb; 35(8):1039-48. PubMed ID: 25961922
[TBL] [Abstract][Full Text] [Related]
4. The pro-tumorigenic activity of p38γ overexpression in nasopharyngeal carcinoma.
Yin DP; Zheng YF; Sun P; Yao MY; Xie LX; Dou XW; Tian Y; Liu JS
Cell Death Dis; 2022 Mar; 13(3):210. PubMed ID: 35246508
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
[TBL] [Abstract][Full Text] [Related]
6. p38γ MAPK Is Essential for Aerobic Glycolysis and Pancreatic Tumorigenesis.
Wang F; Qi XM; Wertz R; Mortensen M; Hagen C; Evans J; Sheinin Y; James M; Liu P; Tsai S; Thomas J; Mackinnon A; Dwinell M; Myers CR; Bartrons Bach R; Fu L; Chen G
Cancer Res; 2020 Aug; 80(16):3251-3264. PubMed ID: 32580961
[TBL] [Abstract][Full Text] [Related]
7. Extracellular signal-regulated kinase induces cyclin D1 and Cdk-2 expression and phosphorylation of retinoblastoma in hepatocellular carcinoma.
Huynh H; Do PT; Nguyen TH; Chow P; Tan PH; Quach TH; Van T; Soo KC; Tran E
Int J Oncol; 2004 Dec; 25(6):1839-47. PubMed ID: 15547725
[TBL] [Abstract][Full Text] [Related]
8. The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway.
Whittaker SR; Walton MI; Garrett MD; Workman P
Cancer Res; 2004 Jan; 64(1):262-72. PubMed ID: 14729633
[TBL] [Abstract][Full Text] [Related]
9. The stress kinase MRK contributes to regulation of DNA damage checkpoints through a p38gamma-independent pathway.
Tosti E; Waldbaum L; Warshaw G; Gross EA; Ruggieri R
J Biol Chem; 2004 Nov; 279(46):47652-60. PubMed ID: 15342622
[TBL] [Abstract][Full Text] [Related]
10. p38gamma overexpression promotes renal cell carcinoma cell growth, proliferation and migration.
Chen XF; Pan YS; Zheng B; Lu Q
Biochem Biophys Res Commun; 2019 Aug; 516(2):466-473. PubMed ID: 31229268
[TBL] [Abstract][Full Text] [Related]
11. Multi-Kinase Inhibitor with Anti-p38γ Activity in Cutaneous T-Cell Lymphoma.
Zhang XH; Nam S; Wu J; Chen CH; Liu X; Li H; McKeithan T; Gong Q; Chan WC; Yin HH; Yuan YC; Pillai R; Querfeld C; Horne D; Chen Y; Rosen ST
J Invest Dermatol; 2018 Nov; 138(11):2377-2387. PubMed ID: 29758280
[TBL] [Abstract][Full Text] [Related]
12. TGF-beta1-induced cell cycle arrest in renal mesangial cells involves inhibition of cyclin E-cdk 2 activation and retinoblastoma protein phosphorylation.
Schoecklmann HO; Rupprecht HD; Zauner I; Sterzel RB
Kidney Int; 1997 Apr; 51(4):1228-36. PubMed ID: 9083291
[TBL] [Abstract][Full Text] [Related]
13. ErbB2 and p38γ MAPK mediate alcohol-induced increase in breast cancer stem cells and metastasis.
Xu M; Ren Z; Wang X; Comer A; Frank JA; Ke ZJ; Huang Y; Zhang Z; Shi X; Wang S; Luo J
Mol Cancer; 2016 Jul; 15(1):52. PubMed ID: 27416801
[TBL] [Abstract][Full Text] [Related]
14. Conditional binding to and cell cycle-regulated inhibition of cyclin-dependent kinase complexes by p27Kip1.
Eblen ST; Fautsch MP; Anders RA; Leof EB
Cell Growth Differ; 1995 Aug; 6(8):915-25. PubMed ID: 8547220
[TBL] [Abstract][Full Text] [Related]
15. p38alpha antagonizes p38gamma activity through c-Jun-dependent ubiquitin-proteasome pathways in regulating Ras transformation and stress response.
Qi X; Pohl NM; Loesch M; Hou S; Li R; Qin JZ; Cuenda A; Chen G
J Biol Chem; 2007 Oct; 282(43):31398-408. PubMed ID: 17724032
[TBL] [Abstract][Full Text] [Related]
16. Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.
Koga H; Sakisaka S; Harada M; Takagi T; Hanada S; Taniguchi E; Kawaguchi T; Sasatomi K; Kimura R; Hashimoto O; Ueno T; Yano H; Kojiro M; Sata M
Hepatology; 2001 May; 33(5):1087-97. PubMed ID: 11343236
[TBL] [Abstract][Full Text] [Related]
17. Targeting p38γ to inhibit human colorectal cancer cell progression.
Su C; Sun Q; Liu S; Wang H; Feng L; Cao Y
Biochem Biophys Res Commun; 2019 Sep; 517(1):172-179. PubMed ID: 31349971
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of cyclin D1 alters cdk 4- and cdk 2-specific phosphorylation of retinoblastoma protein.
Yu B; Lane ME; Pestell RG; Albanese C; Wadler S
Mol Cell Biol Res Commun; 2000 Jun; 3(6):352-9. PubMed ID: 11032757
[TBL] [Abstract][Full Text] [Related]
19. Antiestrogen inhibition of cell cycle progression in breast cancer cells in associated with inhibition of cyclin-dependent kinase activity and decreased retinoblastoma protein phosphorylation.
Watts CK; Brady A; Sarcevic B; deFazio A; Musgrove EA; Sutherland RL
Mol Endocrinol; 1995 Dec; 9(12):1804-13. PubMed ID: 8614416
[TBL] [Abstract][Full Text] [Related]
20. Activation of cyclin-dependent kinases CDC2 and CDK2 in hepatocellular carcinoma.
Li KK; Ng IO; Fan ST; Albrecht JH; Yamashita K; Poon RY
Liver; 2002 Jun; 22(3):259-68. PubMed ID: 12100577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
